Literature DB >> 24512670

Evaluation of an authority innovation-decision: brief alcohol intervention for pregnant women receiving women, infants, and children services at two Illinois health departments.

Imelda K Moise1, David Green, Janine Toth, Peter F Mulhall.   

Abstract

Despite the availability of clinical tools and evidence-based screening recommendations, there has been little discussion regarding screening of prenatal alcohol exposure in community-based settings, including adoption and implementation. This study's aim is to evaluate and validate--through surveys and focus groups--obstacles and challenges that shape efficacious implementation of the BAI at two Illinois health departments. Results suggest that BAI implementation is facilitated by staff perceptions of its benefits, readiness to implement the intervention, and organizational support for it. Limitations of the management information system, ambiguous screening questions, and high case-loads present barriers to effective BAI implementation.

Entities:  

Mesh:

Year:  2014        PMID: 24512670     DOI: 10.3109/10826084.2014.880484

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  3 in total

1.  Adolescent and young adult couples' views of intravaginal practices: a qualitative analysis of a pilot study.

Authors:  Imelda K Moise; Evan de Joya; Benjamin Caplan; Violeta J Rodriguez; Stefani Butts; Maureen Chisembele; Stephen M Weiss; Deborah L Jones; Maria L Alcaide
Journal:  Int J Womens Health       Date:  2019-01-18

2.  Alcohol use, pregnancy and associated risk factors: a pilot cross-sectional study of pregnant women attending prenatal care in an urban city.

Authors:  Imelda K Moise
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-05       Impact factor: 3.007

3.  Providers' Perspectives on Case Management of a Healthy Start Program: A Qualitative Study.

Authors:  Imelda K Moise; Peter F Mulhall
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.